Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
X4 Pharmaceuticals, Inc. (XFOR) had Cash Flow from Financial Activities of $238.63M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$2.57M |
|
$-23.93M |
|
$0.36M |
|
$2.20M |
|
$26.27M |
|
$-23.70M |
|
$-0.23M |
|
$-23.93M |
|
$-23.93M |
|
$-23.93M |
|
$-23.93M |
|
$-23.93M |
|
$-23.93M |
|
$-23.70M |
|
$-23.48M |
|
42.29M |
|
42.29M |
|
$2.25 |
|
$2.25 |
|
| Balance Sheet Financials | |
$261.58M |
|
$0.18M |
|
$28.88M |
|
$290.46M |
|
$25.76M |
|
$76.29M |
|
$78.41M |
|
$104.17M |
|
$186.29M |
|
$159.69M |
|
$186.29M |
|
90.91M |
|
| Cash Flow Statement Financials | |
$-85.62M |
|
$8.15M |
|
|
Cash Flow from Financial Activities |
$238.63M |
$56.48M |
|
$217.85M |
|
$161.38M |
|
$4.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.16 |
|
-- |
|
-- |
|
0.29 |
|
0.41 |
|
85.83% |
|
-922.86% |
|
-922.86% |
|
-- |
|
-931.66% |
|
-931.66% |
|
$-85.62M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.08 |
|
4.48 |
|
20.08 |
|
-12.84% |
|
-14.98% |
|
-8.24% |
|
-9.11% |
|
$2.05 |
|
$-2.02 |
|
$-2.02 |
|